Anti-sLea/CA19-9 Antibody (5B1) from ProteoGenix; catalogue ARO-A22720; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Are you in search of a reliable and high-quality antibody for your biotech research? Look no further than the Anti-sLea/CA19-9 Antibody (5B1). This powerful antibody is specifically designed to target the sLea/CA19-9 antigen, making it an essential tool for various applications in the biotech field.
The Anti-sLea/CA19-9 Antibody (5B1) is a monoclonal antibody that binds to the sLea/CA19-9 antigen, a carbohydrate structure found on various glycoproteins. This antigen is known to be overexpressed in certain types of cancer, making it a valuable target for cancer research and diagnostics.
The Anti-sLea/CA19-9 Antibody (5B1) is primarily used in cancer research, particularly in the detection and diagnosis of pancreatic, gastric, and colorectal cancers. It is also useful in studying the role of sLea/CA19-9 in other diseases and conditions, such as inflammatory bowel disease and liver cirrhosis.
The Anti-sLea/CA19-9 Antibody (5B1) has shown promising results in various experimental use cases. In one study, it was used to successfully detect sLea/CA19-9 in pancreatic cancer cells, demonstrating its potential for early cancer detection. In another study, it was found to be effective in inhibiting the growth of gastric cancer cells, indicating its potential for targeted cancer therapy.
Why Choose Anti-sLea/CA19-9 Antibody (5B1)?
In conclusion, the Anti-sLea/CA19-9 Antibody (5B1) is an essential tool for targeted biotech research. Its high specificity, versatility, and superior quality make it a valuable addition to any laboratory. Don’t miss out on the opportunity to advance your research with this powerful antibody. Order now and experience its exceptional performance for yourself.
ProteoGenix catalogue number ARO-A22720. For research use only.
Target: CA19-9/CA199; Clonality: Monoclonal Antibody; Applications: Functional assay, ELISA, Flow Cyt.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | Functional assay |
|---|---|---|---|---|---|---|---|---|---|
| CA19-9/CA199 |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
